Henry Schein (NSDQ:HSIC) shares dipped today despite fourth-quarter results that topped the consensus forecast. The Melville, N.Y.-based company posted profits of $142.6 million, or 99¢ per share, on sales of $3.2 billion for the three months ended Dec. 26, 2020, for a -56.8% bottom-line slide on sales growth of 18.6%. Adjusted to exclude one-time items, earnings […]
Henry Schein Inc.
Henry Schein buys majority of Prism Medical Products
Henry Schein (NSDQ:HSIC) announced that it acquired a majority ownership position in home medical supply maker Prism Medical Products. Elkin, N.C.-based Prism provides specialty home medical supplies with a core competency in advanced wound care products, according to a news release. The transaction leads Henry Schein Medical to enter an established and growing market for such […]
The 20 largest medical device companies in the world
The information in this year’s annual Big 100 rankings of the world’s largest medical device companies is as interesting as ever. The 100 companies on this year’s list had medical device businesses bringing in a whopping $420.5 billion during their most recent fiscal years — a nearly 6% increase from the 2019 Big 100. But […]
Henry Schein beats The Street, reports massive medical revenue growth
Henry Schein (NSDQ:HSIC) reported third-quarter results that included enormous growth for its medical business as it beat the consensus forecast. The Melville, N.Y.-based company posted profits of $141.7 million, or 99¢ per share, on sales of $2.8 billion for the three months ended Sept. 26, 2020, for a 1% bottom-line gain on sales growth of 13.2%. […]
Henry Schein dips on Q2 losses
Henry Schein (NSDQ:HSIC) shares dipped slightly today on second-quarter losses that still managed to top the consensus forecast. The Melville, N.Y.-based medical device maker posted losses of -$13.3 million, or -8¢ per share, on sales of $1.7 billion for the three months ended June 27, 2020, for a bottom-line slide into the red from profits of […]
MedTech 100 roundup: Markets dip again
Medtech stocks continue to fluctuate amid the COVID-19 pandemic, with a significant dip in the shares belonging to the industry’s biggest names. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 81.88 points at the end of last week (June 26). That total represents a -3.7% decrease […]
Henry Schein execs extend pay cuts
Henry Schein (NSDQ:HSIC) announced that it is continuing certain cost reduction measures, including payroll cuts, amid the COVID-19 pandemic. The Melville, N.Y.-based medical device maker said in a news release that chairman and CEO Stanley Bergman agreed to extend his prior agreement to a temporary reduction of 100% of his base salary from April 6, 2020, […]
U.S. senators demand investigation of Trump COVID-19 supply chain effort
Three U.S. senators today demanded an investigation into Project Air Bridge, a Trump administration supply chain management project to import personal protective equipment (PPE) and other medical supplies during the COVID-19 pandemic. Dubbing the project “opaque,” U.S. Senators Elizabeth Warren (D-Mass.), Chuck Schumer (D-N.Y.) and Richard Blumenthal (D-Conn.) also released new documents and information from […]
MedTech 100 roundup: Stocks open strong in May
Medtech stocks took a dip as April came to a close, but opened May with a strong week as the COVID-19 pandemic continues to affect the economy. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 83.98 points at the end of last week (May 8). That […]
Henry Schein medical sales lead to Street-beating Q1
Henry Schein (NSDQ:HSIC) shares got a boost today on first-quarter results that topped the consensus forecast as medical sales boomed. The Melville, N.Y.-based company posted profits of $130.3 million, or 91¢ per share, on sales of $2.4 billion for the three months ended March 28, 2020, for an 18.7% bottom-line gain on sales growth of 2.9%. […]
BD to launch point-of-care COVID-19 antibody test
Becton Dickinson (NYSE:BDX) yesterday announced a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19 in as little as 15 minutes. The new test, developed and manufactured by BioMedomics (Morrisville, N.C.), will be available through BD and distributed exclusively by Henry Schein (NSDQ:HSIC) to healthcare providers throughout the […]
